Loading

Commentary Open Access
Volume 3 | Issue 1 | DOI: https://doi.org/10.33696/immunology.3.075

Prospects of JAK Inhibition in the Framework of Bone Loss

  • 1Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany
  • 2Deutsches Zentrum für Immuntherapie (DZI), Friedrich Alexander University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany
+ Affiliations - Affiliations

Corresponding Author

Silke Frey, Silke.Frey@uk-erlangen.de

Received Date: November 12, 2020

Accepted Date: January 21, 2021

Keywords

JAKinibs, Bone, Osteoimmunology, Rheumatoid arthritis, Oosteoporosis

Author Information X